Technology
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
CEO Mark Zuckerberg also announced that the company will be using WhatsApp's chatbots to help with vaccine registration.
The analyser is part of an assessment of the AI-based ‘CURIAL’ test to screen for COVID-19 in patients.
The company also revealed new partnerships with AdvancedMd, DrChrono and athenahealth.
Also, mental health website for new mums launches.
The acquisition allows cliexa to meet GI customers with an end-to-end automated scheduling, reporting and communications platform.
The company currently has 11 locations delivering virtual-supported care, but now plans to open "several" more in the first half of 2021.
The Pillcam technology is manufactured by US medical device firm Medtronic.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.